Clinical Cancer Research Landon Prizes for Basic and Translational Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, R.
Right arrow Articles by Huang, R.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, R.
Right arrow Articles by Huang, R.-P.
Clinical Cancer Research Vol. 10, 598-609, January 2004
© 2004 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Enhanced Protein Profiling Arrays with ELISA-Based Amplification for High-Throughput Molecular Changes of Tumor Patients’ Plasma

Ruochun Huang, Ying Lin, Qian Shi, Lisa Flowers, Sumathi Ramachandran, Ira R. Horowitz, Sampath Parthasarathy and Ruo-Pan Huang

Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia

Purpose: The purpose of this study is to develop a high-throughput approach to detect protein expression from hundreds and thousands of samples and to apply this technology to profile circulating angiogenic factor protein levels in patients with gynecological tumors.

Experimental Design: Analytes containing a mixture of protein are immobilized onto antibody-coated surface of support in array format. The presence of protein in analytes is detected with biotin-labeled antibody coupled with an enhanced chemiluminescence or fluorescence detection system. The exact amount of protein can be quantitatively measured. The expression levels of five angiogenic factors (angiogenin, interleukin 8, vascular endothelial growth factor, platelet-derived growth factor, and epidermal growth factor) from 157 samples were quantitatively measured using this novel protein array technology and were statistically analyzed. The expression patterns of angiogenic factors were analyzed using two-way hierarchical cluster analysis approach.

Results: A novel protein array technology, which can simultaneously and quantitatively measure few protein levels from hundreds and thousands of samples was developed. Only minute amounts of sample are required for the assay. This approach also features high sensitivity and specificity. Using this novel protein array approach, we analyzed the plasma expression levels of five angiogenic factors in 137 patients diagnosed with a tumor and 20 controls. Statistical analysis reveals different expression levels of angiogenic factors between patients and controls. Cluster analysis suggests a possible classification of normal subjects from patients.

Conclusions: Enhanced protein profiling arrays provide a high-throughput and sensitive system to detect one or few protein from hundreds and thousands of samples. Such an approach should have broad application in biomedical discovery.




This article has been cited by other articles:


Home page
Clin. Chem.Home page
M. Sanchez-Carbayo
Antibody Arrays: Technical Considerations and Clinical Applications in Cancer
Clin. Chem., September 1, 2006; 52(9): 1651 - 1659.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
B. B. Haab
Using Array-Based Competitive and Noncompetitive Immunoassays
Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 148 - 154.
[Full Text] [PDF]


Home page
Cancer Res.Home page
R. Orchekowski, D. Hamelinck, L. Li, E. Gliwa, M. VanBrocklin, J. A. Marrero, G. F. Vande Woude, Z. Feng, R. Brand, and B. B. Haab
Antibody Microarray Profiling Reveals Individual and Combined Serum Proteins Associated with Pancreatic Cancer
Cancer Res., December 1, 2005; 65(23): 11193 - 11202.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
B. B. Haab
Antibody Arrays in Cancer Research
Mol. Cell. Proteomics, April 1, 2005; 4(4): 377 - 383.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
J. W. Jacobson
Comprehensive Molecular Analysis of Human Specimens
Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 311 - 314.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.